title: Striatal 5-HT6 Receptors Regulate Cocaine Reinforcement in a Pathway-Selective Manner.
abstract: The nucleus accumbens (NAc) in the ventral striatum integrates many neurochemical inputs including dopamine and serotonin projections from midbrain nuclei to modulate drug reward. Although D1 and D2 dopamine receptors are differentially expressed in the direct and indirect pathway medium spiny neurons (dMSNs and iMSNs, respectively), 5-HT6 receptors are expressed in both pathways, more strongly than anywhere else in the brain, and are an intriguing target for neuropsychiatric disorders. In the present study, we used viral vectors utilizing dynorphin or enkephalin promoters to drive expression of 5-HT6 receptors or green fluorescent protein (GFP) selectively in the dMSNs or iMSNs of the NAc shell. Rats were then trained to self-administer cocaine. Increased 5-HT6 receptor expression in dMSNs did not change any parameter of cocaine self-administration measured. However, increasing 5-HT6 receptors in iMSNs reduced the amount of cocaine self-administered under fixed-ratio schedules, especially at low doses, increased the time to the first response and the length of the inter-infusion interval, but did not alter motivation as measured by progressive ratio 'break point' analysis. Modeling of cocaine pharmacokinetics in NAc showed that increased 5-HT6 receptors in iMSNs reduced the rat's preferred tissue cocaine concentration at each dose. Finally, increased 5-HT6 receptors in iMSNs facilitated conditioned place preference for a low dose of cocaine. We conclude that 5-HT6 receptors in iMSNs of NAcSh increase the sensitivity to the reinforcing properties of cocaine, particularly at low doses, suggesting that these receptors may be a therapeutic target for the treatment of cocaine addiction.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.|Department of Pharmacology, University of Washington, Seattle, WA, USA.|Graduate Program in Neuroscience, University of Washington, Seattle, WA, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Brodsky
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.|Department of Pharmacology, University of Washington, Seattle, WA, USA.|Graduate Program in Neuroscience, University of Washington, Seattle, WA, USA.
authors.forename: Alec W
authors.initials: AW
authors.lastname: Gibson
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
authors.forename: Denis
authors.initials: D
authors.lastname: Smirnov
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
authors.forename: Sunila G
authors.initials: SG
authors.lastname: Nair
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.|Department of Pharmacology, University of Washington, Seattle, WA, USA.
authors.forename: John F
authors.initials: JF
authors.lastname: Neumaier
mesh_terms: D000818:Animals; D003042:Cocaine / Q000008:administration & dosage* / Q000032:analysis / Q000493:pharmacokinetics; D003214:Conditioning, Classical / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects; D008124:Locomotion / Q000187:drug effects; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D009714:Nucleus Accumbens / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology; D020318:Rats, Long-Evans; D011985:Receptors, Serotonin / Q000378:metabolism / Q000502:physiology*; D012054:Reinforcement, Psychology; D012646:Self Administration
chemical_list: D011985:Receptors, Serotonin; C097216:serotonin 6 receptor; D003042:Cocaine